Medication

August 01, 2018 - 8:43 am
LONDON (AP) — Pharmaceutical company Sanofi has begun to stockpile more drugs in Britain than usual as part of contingency plans for delays in deliveries after Britain leaves the European Union. Hugo Fry, the managing director of Sanofi UK, says uncertainty in the Brexit negotiations has led to...
Read More
FILE - In this Nov. 23, 2015, file photo, the Pfizer logo is displayed at world headquarters in New York. Pfizer Inc. (PFE) on Tuesday, July 31, 2018, reported second-quarter earnings of $3.87 billion. (AP Photo/Mark Lennihan, File)
July 31, 2018 - 7:57 am
Pfizer's second-quarter profit surged 26 percent, thanks to a 4 percent increase in medicine sales, higher income from partnerships and lower tax expenses. The biggest U.S.-based drugmaker on Tuesday beat Wall Street expectations and boosted its 2018 profit forecast. However, Pfizer trimmed its...
Read More
July 27, 2018 - 8:01 am
Soaring sales of most of its cancer drugs and vaccines boosted Merck & Co.'s second-quarter revenue by 5 percent, but restructuring and acquisition costs helped drag profits down 12 percent. However, revenue and net income both beat Wall Street expectations and the drugmaker raised its profit...
Read More
FILE - This Oct. 7, 2003 file photo shows a section of a human brain with Alzheimer's disease on display at the Museum of Neuroanatomy at the University at Buffalo, in Buffalo, N.Y. On Wednesday, July 25, 2018, two drug makers said an experimental therapy slowed mental decline by 30 percent in patients who got the highest dose in a mid-stage study, and it removed much of the sticky plaque gumming up their brains. The drug, called BAN2401, is from Eisai and Biogen. (AP Photo/David Duprey)
July 25, 2018 - 4:58 pm
CHICAGO (AP) — Hopes are rising again for a drug to alter the course of Alzheimer's disease after repeated failures. An experimental therapy slowed mental decline by 30 percent in patients who got the highest dose in a mid-stage study, and it removed much of the sticky plaque gumming up their...
Read More
In this March 23, 2017 photo provided by the Sunnybrook Health Sciences Centre, patient Rick Karr is prepared for treatment at the facility in Toronto, Canada. Karr was the first Alzheimer's patient treated with focused ultrasound to open the blood-brain barrier. Scientists are using ultrasound waves to temporarily jiggle an opening in the brain’s protective shield, in hopes the technique one day might help drugs for Alzheimer’s, brain tumors and other diseases better reach their target. (Kevin Van Paassen/Sunnybrook Health Sciences Centre via AP)
July 25, 2018 - 4:06 pm
WASHINGTON (AP) — A handful of Alzheimer's patients signed up for a bold experiment: They let scientists beam sound waves into the brain to temporarily jiggle an opening in its protective shield. The so-called blood-brain barrier prevents germs and other damaging substances from leaching in through...
Read More

Pages